Last reviewed · How we verify
oral clomiphene citrate
At a glance
| Generic name | oral clomiphene citrate |
|---|---|
| Also known as | clomid, Clomiphene citrate 100mg/day from cycle day 3 to 7 |
| Sponsor | Ain Shams University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- FRIEND: Fibroids and Unexplained Infertility Treatment With Epigallocatechin Gallate; A Natural CompounD in Green Tea (PHASE3)
- The Effect Of Polycystic Ovarian Syndrome Treatment On Ocular Surface.
- Vaginal Estradiol and Oral Guaifenesin in Clomiphene Ovulation Induction (NA)
- Ovarian Hyperstimulation and Fibrin Clot Properties. (NA)
- Interest of Clomiphene Citrate in Patients With Non-obstructive Azoospermia on the Quantity of Sperm Cells (PHASE3)
- Randomized Controlled Trial of Combined Letrozole and Clomid (CLC II) Versus Letrozole Alone for Women With Anovulation (PHASE4)
- One-shot Ovarian Stimulation Protocol (One-shot) (NA)
- Clomiphene Citrate in Infertile Men With Idiopathic Oligoasthenozoospermia (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- oral clomiphene citrate CI brief — competitive landscape report
- oral clomiphene citrate updates RSS · CI watch RSS
- Ain Shams University portfolio CI